Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.

ORMP · Nasdaq

Oramed Pharmaceuticals Inc. (ORMP) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Oramed Pharmaceuticals Inc. in 2026. The next earnings report is expected on November 16, 2026.

Earnings calendar

Next earnings date

16 Nov 2026

In 87 days

EPS estimate

0.52

Revenue estimate

0

Past earnings

10 Aug 2026
EPS actual
—
estimate 0.43
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
03 Jun 2026
EPS actual
—
estimate -0.08
Revenue actual
—
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
26 Mar 2026
EPS actual
0.00 (+100.0%)
estimate -0.08
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
25 Feb 2026
EPS actual
0.00 (+100.0%)
estimate -0.08
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

Next ex-dividend

—

Not scheduled

Next payment

—

Not scheduled

Dividend amount

—

Not available

Past dividends

Ex-dividend Payment Amount
16 Jan 2026 26 Jan 2026 0.25

EPS (Earnings Per Share)

Revenue

Dividend per share

Company profile

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Nadav Kidron
Employees
13
IPO date
01 May 2007
ISIN
US68403P2039
Website
oramed.com

Frequently asked questions

When does Oramed Pharmaceuticals Inc. (ORMP) next report earnings?

Oramed Pharmaceuticals Inc. (ORMP) is scheduled to report earnings on November 16, 2026.

What was Oramed Pharmaceuticals Inc.'s most recent earnings date?

Oramed Pharmaceuticals Inc. (ORMP) last reported earnings on August 10, 2026.

Where is Oramed Pharmaceuticals Inc. stock listed?

Oramed Pharmaceuticals Inc. (ORMP) is listed on Nasdaq.